Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
222.50    -5.00 (-2.20%)
Bid:
220.00
Ask:
225.00
Spread: 5.00 (2.273%)
Market Cap: £107.81m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Trading Update

10 Oct 2022 07:00

RNS Number : 2327C
Quartix Technologies PLC
10 October 2022
 

Quartix Technologies plc

("Quartix", "the Group" or "the Company")

Trading Update

 

 

Q3 Trading update

 

The Board is pleased to report that the rate of year-on-year growth in both annualised recurring revenue and unit installs continued to be strong in the third quarter.  These growth rates are expected to continue in the last quarter of the year.

The annualised recurring revenue of the fleet subscription base was £26.9m on 1 October, representing a gain, in constant currency terms, of £2.6m year on year, based on exchange rates as at 1 October 2022.

The Company's subscription base has grown by 17% year on year, to just over 229,000 vehicles. New units installed in the first 9 months of the year have increased by 24% compared with the same period in 2021. Growth in new subscriptions for the first 9 months of 2022 are shown in the table below.

 

Region

New subscriptions

(units)

first 9 months 2022

New subscriptions

(units)

first 9 months 2021

Growth

UK

20,714

17,703

17%

France

12,523

8,502

47%

USA

7,269

6,881

6%

Spain, Italy, Germany

6,060

4,586

32%

Total

46,566

37,672

24%

 

The Board is pleased to confirm that it expects revenue, profit and free cash flow for the year to 31 December 2022 to be in line with current consensus market forecasts, which are shown at the foot of this announcement1.

 

Richard Lilwall, CEO of Quartix, commented:

 

"We are delighted with the continuing growth in ARR to £26.9m at the end of the third quarter, in line with our expectations. We are also very pleased with growth in new subscriptions being particularly led by France followed by further progress in other European countries. The UK continues to deliver double digit growth in a more mature market. Our strategy for increasing the subscription base in the US continues to be refined."

 

The Board believes that consensus market expectations for 2022 prior to this announcement, were as follows: Revenue: £27.4m; Adjusted EBITDA £5.7m; Free Cash Flow: £4.1m.

 

 

For further information, please contact:

Quartix (www.quartix.com)

Richard Lilwall, Chief Executive Officer

Emily Rees, Chief Financial Officer

 

01686 806 663

finnCap (Nominated Adviser and Broker)

Matt Goode / Seamus Fricker / Milesh Hindocha (Corporate Finance)

Alice Lane (Corporate Broking)

020 7220 0500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVEIVLDIIF
Date   Source Headline
27th May 20214:25 pmRNSExercise of Share Options, PDMR Shareholding & TVR
25th May 20217:56 amRNSGranting of Options
21st May 20217:00 amRNSDirectorate Changes and Trading Update
26th Mar 20211:57 pmRNSExercise of Options, Director/PDMR Dealing & TVR
23rd Mar 20212:56 pmRNSResult of AGM
23rd Mar 20217:00 amRNSAGM Trading Statement
12th Mar 20211:34 pmRNSExercise of Options, Director/PDMR Dealing & TVR
4th Mar 20211:57 pmRNSExercise of share options and Total Voting Rights
3rd Mar 20217:00 amRNSDividend Timetable and Correction of Record Date
1st Mar 20217:00 amRNSFinal Results
20th Jan 202111:24 amRNSHolding(s) in Company
19th Jan 202111:24 amRNSResult of Secondary Placing
19th Jan 20217:00 amRNSProposed Secondary Placing
11th Jan 20217:00 amRNSTrading Statement
8th Jan 20215:15 pmRNSHolding(s) in Company
6th Jan 20213:11 pmRNSHolding(s) in Company
15th Dec 20204:40 pmRNSSecond Price Monitoring Extn
15th Dec 20204:35 pmRNSPrice Monitoring Extension
22nd Oct 20207:00 amRNSTrading Statement
24th Sep 20207:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20207:00 amRNSInterim Results
17th Jul 20207:00 amRNSNotice of Interim Results
2nd Jun 20207:00 amRNSTrading Statement
27th Apr 20207:00 amRNSTrading Statement
30th Mar 20207:00 amRNSDirector/PDMR Shareholding
25th Mar 20201:10 pmRNSResult of AGM
24th Mar 202012:35 pmRNSExercise of Options and Issue of Equity
24th Mar 20207:00 amRNSAGM Trading Statement
19th Mar 20207:00 amRNSMeasures taken re Coronavirus and Dividend
9th Mar 20203:47 pmRNSPDMR Share Transfer
24th Feb 20207:00 amRNSFinal Results
13th Jan 20207:00 amRNSTrading Statement
23rd Oct 20197:00 amRNSDirectorate Changes
24th Jul 20197:00 amRNSInterim Results
19th Jun 20197:00 amRNSTrading Update
14th May 20198:58 amRNSDirector/PDMR Shareholding
10th May 20195:52 pmRNSHolding(s) in Company
15th Apr 201912:32 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSSenior Appointments
28th Mar 20198:43 amRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSAGM Trading Statement
5th Mar 20197:00 amRNSHolding(s) in Company
25th Feb 20197:00 amRNSFinal Results
22nd Feb 20197:00 amRNSChange of Registered Office
30th Jan 20199:11 amRNSHolding(s) in Company
10th Jan 20197:00 amRNSTrading Statement
5th Dec 20187:00 amRNSExercise and Granting of Options
4th Dec 20187:00 amRNSTrading Statement
4th Oct 20187:00 amRNSBoard Update
13th Aug 20184:12 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.